These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24789846)

  • 1. Prospective population-based study of the association between serum 25-hydroxyvitamin-D levels and the incidence of specific types of cancer.
    Skaaby T; Husemoen LL; Thuesen BH; Pisinger C; Jørgensen T; Roswall N; Larsen SC; Linneberg A
    Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1220-9. PubMed ID: 24789846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Filaggrin loss-of-function mutations and incident cancer: a population-based study.
    Skaaby T; Husemoen LL; Thyssen JP; Meldgaard M; Thuesen BH; Pisinger C; Jørgensen T; Carlsen K; Johansen JD; Menné T; Szecsi PB; Stender S; Linneberg A
    Br J Dermatol; 2014 Dec; 171(6):1407-14. PubMed ID: 24628370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of vitamin D status to risk of cardiovascular disease and mortality.
    Skaaby T
    Dan Med J; 2015 Feb; 62(2):. PubMed ID: 25634511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 25-hydroxyvitamin d and cancer risk in older adults: results from a large German prospective cohort study.
    Ordóñez-Mena JM; Schöttker B; Haug U; Müller H; Köhrle J; Schomburg L; Holleczek B; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2013 May; 22(5):905-16. PubMed ID: 23462913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D levels and cancer incidence in 217,244 individuals from primary health care in Denmark.
    Vojdeman FJ; Madsen CM; Frederiksen K; Durup D; Olsen A; Hansen L; Heegaard AM; Lind B; Tjønneland A; Jørgensen HL; Schwarz P
    Int J Cancer; 2019 Jul; 145(2):338-346. PubMed ID: 30613979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
    Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
    Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopy and development of cancer: a population-based prospective study.
    Skaaby T; Nystrup Husemoen LL; Roswall N; Thuesen BH; Linneberg A
    J Allergy Clin Immunol Pract; 2014; 2(6):779-85. PubMed ID: 25439371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective population-based study of the association between vitamin D status and incidence of autoimmune disease.
    Skaaby T; Husemoen LL; Thuesen BH; Linneberg A
    Endocrine; 2015 Sep; 50(1):231-8. PubMed ID: 25666936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
    Schmutz EA; Zimmermann MB; Rohrmann S
    Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of serum vitamin D and cancer mortality in the United States.
    Freedman DM; Looker AC; Chang SC; Graubard BI
    J Natl Cancer Inst; 2007 Nov; 99(21):1594-602. PubMed ID: 17971526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum 25(OH)D and incident type 2 diabetes: a cohort study.
    Husemoen LL; Skaaby T; Thuesen BH; Jørgensen T; Fenger RV; Linneberg A
    Eur J Clin Nutr; 2012 Dec; 66(12):1309-14. PubMed ID: 23031851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.
    Brodin E; Lerstad G; Grimnes G; Brækkan SK; Vik A; Brox J; Svartberg J; Jorde R; Hansen JB
    Thromb Haemost; 2013 May; 109(5):885-90. PubMed ID: 23446951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association between Serum 25-Hydroxyvitamin D and Cancer Risk: Results from the Prospective KORA F4 Study.
    Cheney CP; Thorand B; Huth C; Berger K; Peters A; Seifert-Klauss V; Kiechle M; Strauch K; Quante AS
    Oncol Res Treat; 2018; 41(3):117-121. PubMed ID: 29485414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D and nonmelanoma skin cancer in a health maintenance organization cohort.
    Eide MJ; Johnson DA; Jacobsen GR; Krajenta RJ; Rao DS; Lim HW; Johnson CC
    Arch Dermatol; 2011 Dec; 147(12):1379-84. PubMed ID: 21844426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and cancer mortality in elderly women.
    Wong G; Lim WH; Lewis J; Craig JC; Turner R; Zhu K; Lim EM; Prince R
    BMC Cancer; 2015 Mar; 15():106. PubMed ID: 25884436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.
    Weinstein SJ; Mondul AM; Yu K; Layne TM; Abnet CC; Freedman ND; Stolzenberg-Solomon RZ; Lim U; Gail MH; Albanes D
    Eur J Epidemiol; 2018 Nov; 33(11):1087-1099. PubMed ID: 30073448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community.
    van der Pols JC; Russell A; Bauer U; Neale RE; Kimlin MG; Green AC
    J Invest Dermatol; 2013 Mar; 133(3):637-641. PubMed ID: 23076499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating 25-hydroxyvitamin D concentration and cause-specific mortality in the Melbourne Collaborative Cohort Study.
    Heath AK; Hodge AM; Ebeling PR; Kvaskoff D; Eyles DW; Giles GG; English DR; Williamson EJ
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105612. PubMed ID: 32007563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma 25-hydroxyvitamin D and high risk of nonmelanoma skin cancer: a Mendelian randomization study of 97 849 individuals.
    Winsløw UC; Nordestgaard BG; Afzal S
    Br J Dermatol; 2018 Jun; 178(6):1388-1395. PubMed ID: 29143981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.